Hosung Min
28Patents
13h-index
20Co-inventors
77Inventor score
Filing activity: May 13, 2002 → Jan 12, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6919426B2 | Peptides and related molecules that modulate nerve growth factor activity | Human Necessities | 106 | Expired |
| US7138370B2 | Specific binding agents of human angiopoietin-2 | Chemistry; Metallurgy | 55 | Expired |
| US7511012B2 | Myostatin binding agents | Physics | 28 | Expired |
| US7205275B2 | Methods of treatment using specific binding agents of human angiopoietin-2 | Chemistry; Metallurgy | 27 | Expired |
| US7803923B2 | Polynucleotides encoding myostatin binding agents | Physics | 23 | Active |
| US7259137B2 | Peptides and related molecules that bind to TALL-1 | Chemistry; Metallurgy | 23 | Expired |
| US7371559B2 | Peptides and related molecules that modulate nerve growth factor activity | Human Necessities | 16 | Expired |
| US7723499B2 | Specific binding agents of human angiopoietin-2 | Chemistry; Metallurgy | 15 | Active |
| US7666839B2 | Methods of treatment using specific binding agents of human angiopoietin-2 | Chemistry; Metallurgy | 15 | Active |
| US8124724B2 | Peptides and related molecules that modulate nerve growth factor activity | Human Necessities | 15 | Active |
| US7666832B2 | Methods of treatment using specific binding agents of human angiopoietin-2 | Chemistry; Metallurgy | 15 | Active |
| US8071538B2 | Method of increasing muscle mass by administering a myostatin binding agent | Physics | 14 | Active |
| US7928075B2 | Binding agents which inhibit myostatin | Physics | 14 | Active |
| US7790674B2 | Methods of treatment using specific binding agents of human angiopoietin-2 | Chemistry; Metallurgy | 10 | Active |
| US8920798B2 | Myostatin binding agents, nucleic acids encoding the same, and methods of treatment | Physics | 9 | Active |
| US8541201B2 | Thrombopoietic compounds | Chemistry; Metallurgy | 9 | Active |
| US7332474B2 | Peptides and related compounds having thrombopoietic activity | Human Necessities | 9 | Expired |
| US9562108B2 | Carrier immunoglobulins | Chemistry; Metallurgy | 8 | Active |
| US7666831B2 | Methods of treatment using specific binding agents of human angiopoietin-2 | Chemistry; Metallurgy | 6 | Active |
| US7737111B2 | Peptides and related molecules that bind to TALL-1 | Chemistry; Metallurgy | 6 | Active |
| US8507426B2 | Peptides and related molecules that bind to TALL-1 | Chemistry; Metallurgy | 4 | Active |
| US7981425B2 | Thrombopoietic compounds | Chemistry; Metallurgy | 2 | Active |
| US9200040B2 | Specific binding agents of human angiopoietin-2 | Chemistry; Metallurgy | 1 | Active |
| US8734796B2 | Carrier immunoglobulins | Chemistry; Metallurgy | 1 | Active |
| US8129331B2 | Specific binding agents of human angiopoietin-2 | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.